Eurofins Discovery

Overview

Eurofins Discovery is a contract research organization specializing in drug discovery services for small molecules and biotherapeutics. With over 40 years of industry leadership, the company accelerates the discovery and development of innovative molecules across all therapeutic areas and modalities.

Service Offerings

The company provides:

• Small Molecule Services — including medicinal chemistry, high-throughput screening, target identification, and computational drug discovery
• Biotherapeutics Services — supporting development across multiple modalities
• Integrated Drug Discovery — end-to-end discovery solutions
• Process Chemistry — process development, route optimization, and kilogram-scale synthesis to bridge discovery and clinical development
• Assay Kits & Reagents — cell-based assay products, cell lines, primary cells, detection kits, recombinant proteins, kinases, and bioassays for biologics
• Safety Pharmacology — modernized in vitro safety assessment
• Target Profiling — SH2 domain profiling and GPCR functional analysis

Capabilities

The organization supports drug discovery projects regardless of modality or therapeutic area, with custom solutions available for specific client needs. The company maintains both service delivery and product lines (DiscoverX brand) to support discovery workflows.